1. 临床病理学(第2版),泌尿系统. 人民卫生出版社,2021年,参编
2. Li MF#, Fang LN#, Kwantwi LB, He GF, Luo WW, Yang LJ, Huang YH, Yin SY, Cai YP, Ma W, Zhan HQ, Tong ZT, Zhang L, Liang CZ*, Yin Y*. N‑Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8. Med Oncol. 2021; 38(10): 127.
3. He GF#, Li MF#, Fang LN#, Xu LF, Huang XJ, Zheng LL, Yang LJ, Luo WW, Cai YP, Ma W, Liang CZ*, Yin Y*. N-Myc induces malignant progress of prostate cancer by regulating FSCN1. Oncology Reports. 2020; 44(5): 2265-2274.
4. Zhu X, Lu KY, Cao LY, Hu Y, Yin Y*, Cai YP*. FoxM1 is upregulated in osteosarcoma and inhibition of FoxM1 decreases osteosarcoma cell proliferation, migration, and invasion. Cancer Management and Research. 2020; 12: 9857-9867.
5. Yin Y#, Xu LF#, Chang Y, Zeng T, Chen XF, Wang AF, Groth J, Foo WC, Liang CZ*, Hu HL*, Huang JT*. N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway. Molecular Cancer. 2019; 18(1): 11.
6. Huang XJ#, Xia Y#, He GF, Zheng LL, Cai YP, Yin Y*, Wu Q*. MALAT1 promotes angiogenesis of breast cancer. Oncology Reports. 2018; 40(5): 2683-2689.
7. Yin Y#, Zhang QF#, Zhang H, He YP, Huang JT*. Molecular signature to risk-stratify prostate cancer of intermediate risk. Clin Cancer Res. 2017; 23(1): 6-8.
8. Feng NH#, Yin Y#, He YP, Huang JT*. Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma. European Urology. 2017; 71(1): 79-80.
9. Li YJ#, Sun JL#, Cai YP, Jiang Y, Wang XJ, Huang XJ, Yin Y*, Li H*. MiR-200a acts as an oncogene in colorectal carcinoma by targeting PTEN. Experimental and Molecular Pathology. 2016: 308-313.
10. Cai YP#, Ma W#, Huang XJ, Cao LY, Li H, Jiang Y, Lu NN, Yin Y*. Effect of survivin on tumor growth of colorectal cancer in vivo. Int J Clin Exp Pathol. 2015; 8(10): 13267-13272.
11. Cao LY#, Chen SH, Zhang C, Chen C, Lu NN, Jiang Y, Cai YP, Yin Y*, Xu JM*. ING4 enhances paclitaxel’s effect on colorectal cancer growth in vitro and in vivo. Int J Clin Exp Pathol. 2015; 8(3): 2919-2927.
12. Yin Y#, Wang T#, Cai YP, Huang XJ, Li YJ, Chen SH, Qin R, Wang CF*, Wu Q*. Microcystic/Reticular Schwannoma of the Mandible: First Case Report and Review of the Literature. Medicine. 2015; 94(45): e1974.
13. Li Q#, Liu X#, Yin Y#, Zheng JT, Jiang CF, Wang J, Wang M, Liu LZ, Jiang BH*, Shen H, Li CY. Insulin Regulates Glucose Consumption and Lactate Production through Reactive Oxygen Species and Pyruvate Kinase M2. Oxid Med Cell Longev. 2014; 2014: 504953.
14. Yin Y#, Yan ZP#, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH*, Liu LZ*. Downregulation of miR-145 associated with cancer progression and VEGF tranional activation by targeting N-RAS and IRS1. Biochimica et Biophysica Acta. 2013; 1829(2): 239-247. (IF=5.456) (JCR 2区)
15. Yin Y#, Yang ZD, Zhang SW*. Combined treatment with exogenous estradiol and progesterone increases the incidence of breast cancer in TA2 mice without ovaries. Cancer Lett. 2011; 311(2): 171-176. (IF=4.864) (JCR 1区)
16. Yin Y#, Cao LY*, Wu WQ, Li H, Jiang Y, Zhang HF. Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. World J Gastroentero. 2010; 16(9): 1086-1092.
17. Cao LY#, Yin Y*, Li H, Jiang Y, Zhang HF. Expression and clinical significance of S100A2 and p63 in esophageal carcinoma. World J Gastroentero. 2009; 15(33): 4183-4188.